Home › Funds › GW&K Investment Management, LLC › CYTK

GW&K Investment Management, LLC position in CYTK

CYTOKINETICS INC · Health Care

GW&K Investment Management, LLC reported holding 1,017,714 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$67.1M, representing 0.57% of its reported portfolio and ranking #48 among its reported holdings. GW&K Investment Management, LLC has disclosed CYTK holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)1.02M sh
Reported value held$67.08M
Portfolio Weight0.57%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GW&K Investment Management, LLC's CYTK position evolved

GW&K Investment Management, LLC first disclosed a stake in CYTK in Q3 2025 at 180,670 shares (US$9.9M). The position peaked in Q2 2026 at 916,107 shares, worth US$78.0M. Across 5 filings, GW&K Investment Management, LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,017,714 shares valued at US$67.1M — an increase of 101,607 shares quarter over quarter.. Notable position changes include a 161% increase in Q4 2025 (shares rose 4% over the following quarter), a 85% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 180.67K $9.93M New
Q4 2025 472.36K $30.02M Add
Q1 2026 494.62K $32.60M Add
Q2 2026 916.11K $78.04M Add
Q3 2026 1.02M $67.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 43 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has GW&K Investment Management, LLC held CYTK?

GW&K Investment Management, LLC has disclosed CYTK holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is GW&K Investment Management, LLC's current position in CYTK?

As of Q3 2026, GW&K Investment Management, LLC holds 1.02M shares of CYTK (CYTOKINETICS INC), valued at $67.08M, representing 0.57% of its reported portfolio and ranking #48.

Has GW&K Investment Management, LLC been buying or selling CYTK?

In the latest 13F filing (Q3 2026), GW&K Investment Management, LLC increased its position in CYTK. The position peaked in Q2 2026 at 916.11K shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.